nodes	percent_of_prediction	percent_of_DWPC	metapath
Entecavir—Decitabine—DNMT1—type 2 diabetes mellitus	0.0129	1	CrCbGaD
Entecavir—Skin disorder—Bromocriptine—type 2 diabetes mellitus	0.00181	0.00184	CcSEcCtD
Entecavir—Gastrointestinal pain—Glipizide—type 2 diabetes mellitus	0.00181	0.00184	CcSEcCtD
Entecavir—Hyperglycaemia—Losartan—type 2 diabetes mellitus	0.0018	0.00183	CcSEcCtD
Entecavir—Hepatitis—Metformin—type 2 diabetes mellitus	0.0018	0.00183	CcSEcCtD
Entecavir—Hepatobiliary disease—Irbesartan—type 2 diabetes mellitus	0.00179	0.00182	CcSEcCtD
Entecavir—Immune system disorder—Valsartan—type 2 diabetes mellitus	0.00179	0.00181	CcSEcCtD
Entecavir—Gastrointestinal disorder—Glimepiride—type 2 diabetes mellitus	0.00179	0.00181	CcSEcCtD
Entecavir—Fatigue—Glimepiride—type 2 diabetes mellitus	0.00178	0.00181	CcSEcCtD
Entecavir—Gastrointestinal disorder—Sitagliptin—type 2 diabetes mellitus	0.00178	0.0018	CcSEcCtD
Entecavir—Fatigue—Sitagliptin—type 2 diabetes mellitus	0.00178	0.0018	CcSEcCtD
Entecavir—Oedema peripheral—Metformin—type 2 diabetes mellitus	0.00178	0.0018	CcSEcCtD
Entecavir—Immune system disorder—Orlistat—type 2 diabetes mellitus	0.00177	0.00179	CcSEcCtD
Entecavir—Renal failure—Losartan—type 2 diabetes mellitus	0.00175	0.00178	CcSEcCtD
Entecavir—Abdominal pain—Glipizide—type 2 diabetes mellitus	0.00175	0.00177	CcSEcCtD
Entecavir—Alopecia—Valsartan—type 2 diabetes mellitus	0.00175	0.00177	CcSEcCtD
Entecavir—Mental disorder—Valsartan—type 2 diabetes mellitus	0.00173	0.00176	CcSEcCtD
Entecavir—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.00173	0.00175	CcSEcCtD
Entecavir—Alopecia—Orlistat—type 2 diabetes mellitus	0.00173	0.00175	CcSEcCtD
Entecavir—Malnutrition—Valsartan—type 2 diabetes mellitus	0.00172	0.00175	CcSEcCtD
Entecavir—Mental disorder—Orlistat—type 2 diabetes mellitus	0.00171	0.00174	CcSEcCtD
Entecavir—Malnutrition—Orlistat—type 2 diabetes mellitus	0.0017	0.00173	CcSEcCtD
Entecavir—Vomiting—Repaglinide—type 2 diabetes mellitus	0.0017	0.00173	CcSEcCtD
Entecavir—Hepatitis—Irbesartan—type 2 diabetes mellitus	0.0017	0.00172	CcSEcCtD
Entecavir—Gastrointestinal pain—Glimepiride—type 2 diabetes mellitus	0.00169	0.00171	CcSEcCtD
Entecavir—Rash—Repaglinide—type 2 diabetes mellitus	0.00169	0.00171	CcSEcCtD
Entecavir—Insomnia—Bromocriptine—type 2 diabetes mellitus	0.00169	0.00171	CcSEcCtD
Entecavir—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.00169	0.00171	CcSEcCtD
Entecavir—Gastrointestinal pain—Sitagliptin—type 2 diabetes mellitus	0.00169	0.00171	CcSEcCtD
Entecavir—Pancreatitis—Ramipril—type 2 diabetes mellitus	0.00168	0.0017	CcSEcCtD
Entecavir—Leukopenia—Gliclazide—type 2 diabetes mellitus	0.00168	0.0017	CcSEcCtD
Entecavir—Headache—Repaglinide—type 2 diabetes mellitus	0.00168	0.0017	CcSEcCtD
Entecavir—Oedema peripheral—Irbesartan—type 2 diabetes mellitus	0.00168	0.0017	CcSEcCtD
Entecavir—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.00167	0.0017	CcSEcCtD
Entecavir—Nervous system disorder—Glyburide—type 2 diabetes mellitus	0.00167	0.00169	CcSEcCtD
Entecavir—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.00166	0.00168	CcSEcCtD
Entecavir—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	0.00164	0.00166	CcSEcCtD
Entecavir—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.00163	0.00166	CcSEcCtD
Entecavir—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.00163	0.00165	CcSEcCtD
Entecavir—Immune system disorder—Metformin—type 2 diabetes mellitus	0.00163	0.00165	CcSEcCtD
Entecavir—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.00161	0.00163	CcSEcCtD
Entecavir—Fatigue—Bromocriptine—type 2 diabetes mellitus	0.00161	0.00163	CcSEcCtD
Entecavir—Neutropenia—Ramipril—type 2 diabetes mellitus	0.0016	0.00163	CcSEcCtD
Entecavir—Hepatitis—Losartan—type 2 diabetes mellitus	0.0016	0.00162	CcSEcCtD
Entecavir—Rash—Rosiglitazone—type 2 diabetes mellitus	0.0016	0.00162	CcSEcCtD
Entecavir—Upper respiratory tract infection—Ramipril—type 2 diabetes mellitus	0.00159	0.00162	CcSEcCtD
Entecavir—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.00159	0.00162	CcSEcCtD
Entecavir—Nausea—Repaglinide—type 2 diabetes mellitus	0.00159	0.00161	CcSEcCtD
Entecavir—Asthenia—Glipizide—type 2 diabetes mellitus	0.00159	0.00161	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.00159	0.00161	CcSEcCtD
Entecavir—Headache—Rosiglitazone—type 2 diabetes mellitus	0.00159	0.00161	CcSEcCtD
Entecavir—Malnutrition—Metformin—type 2 diabetes mellitus	0.00157	0.00159	CcSEcCtD
Entecavir—Immune system disorder—Irbesartan—type 2 diabetes mellitus	0.00154	0.00156	CcSEcCtD
Entecavir—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.00153	0.00155	CcSEcCtD
Entecavir—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.00152	0.00154	CcSEcCtD
Entecavir—Infection—Gliclazide—type 2 diabetes mellitus	0.00152	0.00154	CcSEcCtD
Entecavir—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.00152	0.00154	CcSEcCtD
Entecavir—Renal failure—Ramipril—type 2 diabetes mellitus	0.0015	0.00152	CcSEcCtD
Entecavir—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.0015	0.00152	CcSEcCtD
Entecavir—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.0015	0.00152	CcSEcCtD
Entecavir—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.0015	0.00152	CcSEcCtD
Entecavir—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.00149	0.00151	CcSEcCtD
Entecavir—Asthenia—Glimepiride—type 2 diabetes mellitus	0.00148	0.0015	CcSEcCtD
Entecavir—Malnutrition—Irbesartan—type 2 diabetes mellitus	0.00148	0.0015	CcSEcCtD
Entecavir—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.00148	0.0015	CcSEcCtD
Entecavir—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.00147	0.00149	CcSEcCtD
Entecavir—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.00147	0.00149	CcSEcCtD
Entecavir—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.00147	0.00149	CcSEcCtD
Entecavir—Dizziness—Glipizide—type 2 diabetes mellitus	0.00147	0.00148	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.00146	0.00148	CcSEcCtD
Entecavir—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.00145	0.00147	CcSEcCtD
Entecavir—Hepatobiliary disease—Ramipril—type 2 diabetes mellitus	0.00145	0.00147	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.00144	0.00146	CcSEcCtD
Entecavir—Alopecia—Losartan—type 2 diabetes mellitus	0.00142	0.00143	CcSEcCtD
Entecavir—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.00141	0.00143	CcSEcCtD
Entecavir—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.00141	0.00143	CcSEcCtD
Entecavir—Vomiting—Glipizide—type 2 diabetes mellitus	0.00141	0.00143	CcSEcCtD
Entecavir—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.00141	0.00143	CcSEcCtD
Entecavir—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.0014	0.00142	CcSEcCtD
Entecavir—Infection—Valsartan—type 2 diabetes mellitus	0.0014	0.00142	CcSEcCtD
Entecavir—Rash—Glipizide—type 2 diabetes mellitus	0.0014	0.00142	CcSEcCtD
Entecavir—Dermatitis—Glipizide—type 2 diabetes mellitus	0.0014	0.00141	CcSEcCtD
Entecavir—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.00139	0.00141	CcSEcCtD
Entecavir—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.00139	0.00141	CcSEcCtD
Entecavir—Headache—Glipizide—type 2 diabetes mellitus	0.00139	0.00141	CcSEcCtD
Entecavir—Insomnia—Gliclazide—type 2 diabetes mellitus	0.00139	0.0014	CcSEcCtD
Entecavir—Infection—Orlistat—type 2 diabetes mellitus	0.00138	0.0014	CcSEcCtD
Entecavir—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.00138	0.0014	CcSEcCtD
Entecavir—Hepatitis—Ramipril—type 2 diabetes mellitus	0.00137	0.00139	CcSEcCtD
Entecavir—Dizziness—Glimepiride—type 2 diabetes mellitus	0.00137	0.00139	CcSEcCtD
Entecavir—Skin disorder—Valsartan—type 2 diabetes mellitus	0.00137	0.00138	CcSEcCtD
Entecavir—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.00136	0.00138	CcSEcCtD
Entecavir—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.00136	0.00138	CcSEcCtD
Entecavir—Somnolence—Gliclazide—type 2 diabetes mellitus	0.00136	0.00138	CcSEcCtD
Entecavir—Oedema peripheral—Ramipril—type 2 diabetes mellitus	0.00135	0.00137	CcSEcCtD
Entecavir—Skin disorder—Orlistat—type 2 diabetes mellitus	0.00135	0.00137	CcSEcCtD
Entecavir—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.00135	0.00137	CcSEcCtD
Entecavir—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.00135	0.00137	CcSEcCtD
Entecavir—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.00134	0.00136	CcSEcCtD
Entecavir—Headache—Pioglitazone—type 2 diabetes mellitus	0.00133	0.00135	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.00133	0.00134	CcSEcCtD
Entecavir—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.00133	0.00134	CcSEcCtD
Entecavir—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.00132	0.00134	CcSEcCtD
Entecavir—Fatigue—Gliclazide—type 2 diabetes mellitus	0.00132	0.00134	CcSEcCtD
Entecavir—Nausea—Glipizide—type 2 diabetes mellitus	0.00132	0.00133	CcSEcCtD
Entecavir—Vomiting—Glimepiride—type 2 diabetes mellitus	0.00131	0.00133	CcSEcCtD
Entecavir—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.00131	0.00133	CcSEcCtD
Entecavir—Rash—Glimepiride—type 2 diabetes mellitus	0.0013	0.00132	CcSEcCtD
Entecavir—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.0013	0.00132	CcSEcCtD
Entecavir—Rash—Sitagliptin—type 2 diabetes mellitus	0.0013	0.00132	CcSEcCtD
Entecavir—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.0013	0.00132	CcSEcCtD
Entecavir—Headache—Glimepiride—type 2 diabetes mellitus	0.0013	0.00131	CcSEcCtD
Entecavir—Headache—Sitagliptin—type 2 diabetes mellitus	0.00129	0.00131	CcSEcCtD
Entecavir—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.00128	0.00129	CcSEcCtD
Entecavir—Infection—Metformin—type 2 diabetes mellitus	0.00127	0.00129	CcSEcCtD
Entecavir—Insomnia—Valsartan—type 2 diabetes mellitus	0.00127	0.00129	CcSEcCtD
Entecavir—Insomnia—Orlistat—type 2 diabetes mellitus	0.00126	0.00127	CcSEcCtD
Entecavir—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.00126	0.00127	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.00125	0.00127	CcSEcCtD
Entecavir—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.00125	0.00127	CcSEcCtD
Entecavir—Somnolence—Valsartan—type 2 diabetes mellitus	0.00125	0.00127	CcSEcCtD
Entecavir—Leukopenia—Losartan—type 2 diabetes mellitus	0.00125	0.00126	CcSEcCtD
Entecavir—Skin disorder—Metformin—type 2 diabetes mellitus	0.00124	0.00126	CcSEcCtD
Entecavir—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.00124	0.00126	CcSEcCtD
Entecavir—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.00124	0.00125	CcSEcCtD
Entecavir—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.00123	0.00125	CcSEcCtD
Entecavir—Nausea—Glimepiride—type 2 diabetes mellitus	0.00123	0.00124	CcSEcCtD
Entecavir—Nausea—Sitagliptin—type 2 diabetes mellitus	0.00122	0.00124	CcSEcCtD
Entecavir—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.00122	0.00124	CcSEcCtD
Entecavir—Asthenia—Glyburide—type 2 diabetes mellitus	0.00122	0.00124	CcSEcCtD
Entecavir—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.00121	0.00123	CcSEcCtD
Entecavir—Alopecia—Ramipril—type 2 diabetes mellitus	0.00121	0.00123	CcSEcCtD
Entecavir—Fatigue—Valsartan—type 2 diabetes mellitus	0.00121	0.00123	CcSEcCtD
Entecavir—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.00121	0.00123	CcSEcCtD
Entecavir—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.00121	0.00123	CcSEcCtD
Entecavir—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.00121	0.00122	CcSEcCtD
Entecavir—Mental disorder—Ramipril—type 2 diabetes mellitus	0.0012	0.00122	CcSEcCtD
Entecavir—Infection—Irbesartan—type 2 diabetes mellitus	0.0012	0.00122	CcSEcCtD
Entecavir—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.0012	0.00122	CcSEcCtD
Entecavir—Fatigue—Orlistat—type 2 diabetes mellitus	0.0012	0.00121	CcSEcCtD
Entecavir—Malnutrition—Ramipril—type 2 diabetes mellitus	0.0012	0.00121	CcSEcCtD
Entecavir—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.00119	0.0012	CcSEcCtD
Entecavir—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.00119	0.0012	CcSEcCtD
Entecavir—Rash—Bromocriptine—type 2 diabetes mellitus	0.00118	0.00119	CcSEcCtD
Entecavir—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.00118	0.00119	CcSEcCtD
Entecavir—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.00117	0.00119	CcSEcCtD
Entecavir—Headache—Bromocriptine—type 2 diabetes mellitus	0.00117	0.00118	CcSEcCtD
Entecavir—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.00117	0.00118	CcSEcCtD
Entecavir—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.00115	0.00117	CcSEcCtD
Entecavir—Somnolence—Metformin—type 2 diabetes mellitus	0.00114	0.00115	CcSEcCtD
Entecavir—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.00114	0.00115	CcSEcCtD
Entecavir—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.00114	0.00115	CcSEcCtD
Entecavir—Infection—Losartan—type 2 diabetes mellitus	0.00113	0.00115	CcSEcCtD
Entecavir—Dyspepsia—Metformin—type 2 diabetes mellitus	0.00113	0.00114	CcSEcCtD
Entecavir—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.00112	0.00113	CcSEcCtD
Entecavir—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.00111	0.00113	CcSEcCtD
Entecavir—Nausea—Bromocriptine—type 2 diabetes mellitus	0.00111	0.00112	CcSEcCtD
Entecavir—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.00111	0.00112	CcSEcCtD
Entecavir—Fatigue—Metformin—type 2 diabetes mellitus	0.0011	0.00112	CcSEcCtD
Entecavir—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.0011	0.00111	CcSEcCtD
Entecavir—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.0011	0.00111	CcSEcCtD
Entecavir—Asthenia—Gliclazide—type 2 diabetes mellitus	0.0011	0.00111	CcSEcCtD
Entecavir—Vomiting—Glyburide—type 2 diabetes mellitus	0.00108	0.0011	CcSEcCtD
Entecavir—Rash—Glyburide—type 2 diabetes mellitus	0.00108	0.00109	CcSEcCtD
Entecavir—Somnolence—Irbesartan—type 2 diabetes mellitus	0.00107	0.00109	CcSEcCtD
Entecavir—Dermatitis—Glyburide—type 2 diabetes mellitus	0.00107	0.00109	CcSEcCtD
Entecavir—Leukopenia—Ramipril—type 2 diabetes mellitus	0.00107	0.00108	CcSEcCtD
Entecavir—Headache—Glyburide—type 2 diabetes mellitus	0.00107	0.00108	CcSEcCtD
Entecavir—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.00106	0.00108	CcSEcCtD
Entecavir—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.00105	0.00106	CcSEcCtD
Entecavir—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.00105	0.00106	CcSEcCtD
Entecavir—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.00104	0.00106	CcSEcCtD
Entecavir—Fatigue—Irbesartan—type 2 diabetes mellitus	0.00104	0.00106	CcSEcCtD
Entecavir—Insomnia—Losartan—type 2 diabetes mellitus	0.00103	0.00104	CcSEcCtD
Entecavir—Nausea—Glyburide—type 2 diabetes mellitus	0.00101	0.00103	CcSEcCtD
Entecavir—Abdominal pain—Metformin—type 2 diabetes mellitus	0.00101	0.00103	CcSEcCtD
Entecavir—Dizziness—Gliclazide—type 2 diabetes mellitus	0.00101	0.00103	CcSEcCtD
Entecavir—Somnolence—Losartan—type 2 diabetes mellitus	0.00101	0.00102	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.00101	0.00102	CcSEcCtD
Entecavir—Asthenia—Valsartan—type 2 diabetes mellitus	0.00101	0.00102	CcSEcCtD
Entecavir—Dyspepsia—Losartan—type 2 diabetes mellitus	0.001	0.00101	CcSEcCtD
Entecavir—Asthenia—Orlistat—type 2 diabetes mellitus	0.000997	0.00101	CcSEcCtD
Entecavir—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000989	0.001	CcSEcCtD
Entecavir—Fatigue—Losartan—type 2 diabetes mellitus	0.000981	0.000994	CcSEcCtD
Entecavir—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000976	0.000988	CcSEcCtD
Entecavir—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000974	0.000986	CcSEcCtD
Entecavir—Rash—Gliclazide—type 2 diabetes mellitus	0.000966	0.000978	CcSEcCtD
Entecavir—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000965	0.000977	CcSEcCtD
Entecavir—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000963	0.000975	CcSEcCtD
Entecavir—Headache—Gliclazide—type 2 diabetes mellitus	0.000959	0.000972	CcSEcCtD
Entecavir—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000957	0.000969	CcSEcCtD
Entecavir—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000956	0.000968	CcSEcCtD
Entecavir—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000956	0.000968	CcSEcCtD
Entecavir—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000951	0.000964	CcSEcCtD
Entecavir—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000948	0.00096	CcSEcCtD
Entecavir—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.00093	0.000943	CcSEcCtD
Entecavir—Dizziness—Valsartan—type 2 diabetes mellitus	0.00093	0.000943	CcSEcCtD
Entecavir—Dizziness—Orlistat—type 2 diabetes mellitus	0.000919	0.000931	CcSEcCtD
Entecavir—Asthenia—Metformin—type 2 diabetes mellitus	0.000919	0.000931	CcSEcCtD
Entecavir—Nausea—Gliclazide—type 2 diabetes mellitus	0.00091	0.000922	CcSEcCtD
Entecavir—Body temperature increased—Losartan—type 2 diabetes mellitus	0.0009	0.000911	CcSEcCtD
Entecavir—Abdominal pain—Losartan—type 2 diabetes mellitus	0.0009	0.000911	CcSEcCtD
Entecavir—Vomiting—Valsartan—type 2 diabetes mellitus	0.000895	0.000906	CcSEcCtD
Entecavir—Rash—Valsartan—type 2 diabetes mellitus	0.000887	0.000899	CcSEcCtD
Entecavir—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000886	0.000898	CcSEcCtD
Entecavir—Vomiting—Orlistat—type 2 diabetes mellitus	0.000884	0.000896	CcSEcCtD
Entecavir—Insomnia—Ramipril—type 2 diabetes mellitus	0.000882	0.000894	CcSEcCtD
Entecavir—Headache—Valsartan—type 2 diabetes mellitus	0.000881	0.000893	CcSEcCtD
Entecavir—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000877	0.000888	CcSEcCtD
Entecavir—Rash—Orlistat—type 2 diabetes mellitus	0.000877	0.000888	CcSEcCtD
Entecavir—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000876	0.000887	CcSEcCtD
Entecavir—Headache—Orlistat—type 2 diabetes mellitus	0.000871	0.000882	CcSEcCtD
Entecavir—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000868	0.000879	CcSEcCtD
Entecavir—Somnolence—Ramipril—type 2 diabetes mellitus	0.000867	0.000879	CcSEcCtD
Entecavir—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000859	0.00087	CcSEcCtD
Entecavir—Dizziness—Metformin—type 2 diabetes mellitus	0.000847	0.000858	CcSEcCtD
Entecavir—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000842	0.000853	CcSEcCtD
Entecavir—Fatigue—Ramipril—type 2 diabetes mellitus	0.000841	0.000852	CcSEcCtD
Entecavir—Nausea—Valsartan—type 2 diabetes mellitus	0.000836	0.000847	CcSEcCtD
Entecavir—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000827	0.000838	CcSEcCtD
Entecavir—Nausea—Orlistat—type 2 diabetes mellitus	0.000826	0.000837	CcSEcCtD
Entecavir—Asthenia—Losartan—type 2 diabetes mellitus	0.000816	0.000827	CcSEcCtD
Entecavir—Vomiting—Metformin—type 2 diabetes mellitus	0.000815	0.000825	CcSEcCtD
Entecavir—Rash—Metformin—type 2 diabetes mellitus	0.000808	0.000818	CcSEcCtD
Entecavir—Dermatitis—Metformin—type 2 diabetes mellitus	0.000807	0.000818	CcSEcCtD
Entecavir—Headache—Metformin—type 2 diabetes mellitus	0.000803	0.000813	CcSEcCtD
Entecavir—Dizziness—Irbesartan—type 2 diabetes mellitus	0.0008	0.00081	CcSEcCtD
Entecavir—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000798	0.000808	CcSEcCtD
Entecavir—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000779	0.000789	CcSEcCtD
Entecavir—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000771	0.000781	CcSEcCtD
Entecavir—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000771	0.000781	CcSEcCtD
Entecavir—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000769	0.000779	CcSEcCtD
Entecavir—Rash—Irbesartan—type 2 diabetes mellitus	0.000762	0.000772	CcSEcCtD
Entecavir—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000762	0.000772	CcSEcCtD
Entecavir—Nausea—Metformin—type 2 diabetes mellitus	0.000761	0.000771	CcSEcCtD
Entecavir—Headache—Irbesartan—type 2 diabetes mellitus	0.000757	0.000767	CcSEcCtD
Entecavir—Dizziness—Losartan—type 2 diabetes mellitus	0.000752	0.000762	CcSEcCtD
Entecavir—Vomiting—Losartan—type 2 diabetes mellitus	0.000723	0.000733	CcSEcCtD
Entecavir—Nausea—Irbesartan—type 2 diabetes mellitus	0.000718	0.000728	CcSEcCtD
Entecavir—Rash—Losartan—type 2 diabetes mellitus	0.000717	0.000727	CcSEcCtD
Entecavir—Dermatitis—Losartan—type 2 diabetes mellitus	0.000717	0.000726	CcSEcCtD
Entecavir—Headache—Losartan—type 2 diabetes mellitus	0.000713	0.000722	CcSEcCtD
Entecavir—Asthenia—Ramipril—type 2 diabetes mellitus	0.0007	0.000709	CcSEcCtD
Entecavir—Nausea—Losartan—type 2 diabetes mellitus	0.000676	0.000685	CcSEcCtD
Entecavir—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000668	0.000676	CcSEcCtD
Entecavir—Dizziness—Ramipril—type 2 diabetes mellitus	0.000645	0.000654	CcSEcCtD
Entecavir—Vomiting—Ramipril—type 2 diabetes mellitus	0.00062	0.000628	CcSEcCtD
Entecavir—Rash—Ramipril—type 2 diabetes mellitus	0.000615	0.000623	CcSEcCtD
Entecavir—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000615	0.000623	CcSEcCtD
Entecavir—Headache—Ramipril—type 2 diabetes mellitus	0.000611	0.000619	CcSEcCtD
Entecavir—Nausea—Ramipril—type 2 diabetes mellitus	0.00058	0.000587	CcSEcCtD
